Anthera Pharmaceuticals, Inc. is a biopharmaceutical company focused on advancing the development and commercialization of innovative medicines that benefit patients with unmet medical needs. Anthera has two product candidates, Sollpura, in Phase 3 development for Exocrine Pancreatic Insufficiency due to Cystic Fibrosis and blisibimod, in Phase 2 development for IgA nephropathy. NASDAQ: ANTH
View Top Employees from Anthera PharmaceuticalsWebsite | http://www.anthera.com |
Ticker | ANTH |
Revenue | $9.6 million |
Funding | $42 million |
Employees | 19 (10 on RocketReach) |
Founded | 2004 |
Address | 25801 Industrial Blvd. Ste. B, Hayward, California 94545, US |
Phone | (510) 856-5600 |
Fax | (510) 856-5597 |
Technologies |
JavaScript,
HTML,
PHP
+22 more
(view full list)
|
Industry | Biotechnology, Pharmaceuticals, Healthcare, Pharmaceutical, Science and Engineering, Drug Manufacturing & Research, Health Care, Drug Development |
Web Rank | 14 Million |
Keywords | Blisibimod Lupus Fda, Anthera Statins, Paul Truex, Anthera Pharmaceuticals, Anthera |
Competitors | Alder BioPharmaceuticals, Inc., Sorrento Therapeutics, Inc., XBiotech USA, Inc., XOMA |
SIC | SIC Code 283 Companies, SIC Code 28 Companies |
NAICS | NAICS Code 32 Companies, NAICS Code 325412 Companies, NAICS Code 32541 Companies, NAICS Code 3254 Companies, NAICS Code 325 Companies |
Looking for a particular Anthera Pharmaceuticals employee's phone or email?
The Anthera Pharmaceuticals annual revenue was $9.6 million in 2023.
Dave Thompson is the Director of Anthera Pharmaceuticals.
10 people are employed at Anthera Pharmaceuticals.
Anthera Pharmaceuticals is based in Hayward, California.
The NAICS codes for Anthera Pharmaceuticals are [32, 325412, 32541, 3254, 325].
The SIC codes for Anthera Pharmaceuticals are [283, 28].